Melatonin Market, By Application (Dietary Supplements, Medicine, Food & Beverages, Others), and By Region (North America, Europe, Asia Pacific, Latin America, MEA) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Melatonin is a hormone that helps in regulating the sleep-wake cycle and is produced naturally in the body. It is synthetically produced in a laboratory for treating short-term treatment of insomnia. It has antioxidant properties which expand its applications across pharmaceuticals, food & beverages, and dietary supplements.
Market Dynamics
Increasing use of melatonin in the production of bio-based spray polyurethane foam (SPF) for construction & building insulation is expected to provide potential opportunities in the near future. This is attributed to the growth in the construction industry due to rapidly growing urbanization and industrialization around the globe coupled with the increasing populations. Thus growing demand for melatonin from the construction industry is expected to propel the market growth.
Growth in the food &beverage industry is expected to augment the market growth of the melatonin. Increasing consumer spending on the food products coupled with the growing demand for various food products is expected to propel the market growth of the melatonin. According to the United States Department of Agriculture Economic Research Service, in 2021, food spending by U.S. consumers, businesses and government entities was valued $1.77 trillion.
Key features of the study:
This report provides in-depth analysis of the global melatonin market and provides market size (US$ Million & Tons) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by key players
This study also provides impact analysis of Coronavirus (Covid-19) pandemic on global melatonin market.
It profiles key players in the global melatonin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study Natrol Inc., Neurim Pharmaceuticals Ltd., Pulse Pharmaceuticals Pvt. Ltd., Flynn Pharma Ltd., Fidia Farmaceutici S.P.A., Aspen Pharmacare Holdings Ltd., Schiff Nutrition International Inc., Solal Technologies (Pty) Ltd., Rexall Sundown, Inc., and Bebida Beverage Co.
Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology upgradation, market expansion, and marketing tactics
The global melatonin market report caters to various stakeholders in this industry including investors, suppliers, global soy and milk protein ingredients manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global melatonin market
Detailed Segmentation:
Global Melatonin Market, By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Global melatonin market, By Region:
North America
U.S.
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Canada
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Europe
U.K.
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Germany
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
France
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Italy
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Spain
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Russia
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Rest of Europe
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Asia Pacific
China
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
India
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Japan
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
ASEAN
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Australia
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
South Korea
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Rest of Asia Pacific
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Latin America
Brazil
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Mexico
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Rest of Latin America
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Middle East & Africa
Middle East
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Africa
By Application:
Dietary Supplements
Medicine
Food & Beverages
Others
Company Profiles
Natrol Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
Neurim Pharmaceuticals Ltd.
Pulse Pharmaceuticals Pvt. Ltd.
Flynn Pharma Ltd.
Fidia Farmaceutici S.P.A.
Aspen Pharmacare Holdings Ltd.
Schiff Nutrition Internatoional Inc.
Solal Technologies (Pty) Ltd.
Rexall Sundown, Inc
Bebida Beverage Co.
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook